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Interrupted time series study 
found mixed effects of the impact 
of the Bavarian smoke‑free 
legislation on pregnancy outcomes
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Jasper V. Been4, Nicholas Lack5, Daniela Koller1,2, Werner Maier6 & Eva A. Rehfuess1,2
In 2007 the German government passed smoke‑free legislation, leaving the details of implementation 
to the individual federal states. In January 2008 Bavaria implemented one of the strictest laws in 
Germany. We investigated its impact on pregnancy outcomes and applied an interrupted time 
series (ITS) study design to assess any changes in preterm birth, small for gestational age (primary 
outcomes), and low birth weight, stillbirth and very preterm birth. We included 1,236,992 singleton 
births, comprising 83,691 preterm births and 112,143 small for gestational age newborns. For most 
outcomes we observed unclear effects. For very preterm births, we found an immediate drop of 10.4% 
(95%CI − 15.8, − 4.6%; p = 0.0006) and a gradual decrease of 0.5% (95%CI − 0.7, − 0.2%, p = 0.0010) after 
implementation of the legislation. The majority of subgroup and sensitivity analyses confirm these 
results. Although we found no statistically significant effect of the Bavarian smoke‑free legislation on 
most pregnancy outcomes, a substantial decrease in very preterm births was observed. We cannot 
rule out that despite our rigorous methods and robustness checks, design‑inherent limitations of 
the ITS study as well as country‑specific factors, such as the ambivalent German policy context have 
influenced our estimation of the effects of the legislation.
Over the past two decades, a range of policies and programmes at global, national and regional levels have been 
designed to reduce the detrimental harms associated with tobacco  use1,2. There is strong evidence that smoke-free 
legislation improves adult health outcomes, such as cardiovascular health and mortality from smoking-related 
 illnesses3. There is also evidence that smoke-free legislation improves pregnancy outcomes and child  health3,4. 
For example, a recent systematic review found reductions in preterm birth rates, perinatal mortality and hospital 
attendance rates for asthma following smoke-free  legislation4. However, findings are not fully consistent and 
based on less rigorous study  methods3,4, and more rigorous studies are needed to strengthen the evidence  base5.
Since ratification of the World Health Organization (WHO) Framework Convention on Tobacco Control 
(FCTC) in 2004, Germany is obliged by international law to implement appropriate measures to reduce and 
prevent tobacco consumption and second-hand smoke (SHS)  exposure6. Germany prohibited smoking in the 
workplace in  20047. In 2007 a national law was passed to protect non-smokers from the harmful consequences 
of SHS and required the implementation of federal state level legislation to prohibit smoking in public  places8. 
Sargent et al.9 investigated the short-term effects of the smoke-free legislation on the national level and found a 
significant decrease in hospital admissions due to acute coronary events after implementation of the smoke-free 
legislation. No study, however, has assessed the effects of the smoke-free legislation on pregnancy outcomes in 
the German context.
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In this study, we assess the impact of the smoke-free legislation on pregnancy outcomes implemented on 1 
January 2008 in Bavaria, Germany’s largest and second most populous state with more than 12.5 million inhabit-
ants and approximately one-sixth of all births in  Germany10.
Results
There were 1,290,487 deliveries between 1 January 2005 and 31 December 2016. Due to the standardized data 
collection process related to Bavarian hospital births, there are no missing data of hospital births. We excluded 
53,495 births (4.15%) because inclusion criteria were not met (see Fig. 1). The analysed time series thus included 
1,236,992 singleton deliveries, which represents a monthly mean of 8,950 births (range 7,266–10,825). The 
number of births per month increased steadily over the last 5 years of the study period (see Supplementary 
Fig. S1 online).
Overall, there were 83,691 preterm births (< 37 gestational weeks) during the study period. During the same 
time span there were 112,143 babies born small for gestational age (SGA) (< 10th percentile) and 60,763 born 
with low birth weight (< 2500 g); 11,001 were very preterm births (< 32 gestational weeks) and 3,109 deliveries 
were stillbirths (intrauterine death > 500 g). Maternal, newborn and subgroup characteristics are specified in 
Table 1. Throughout the study period, the outcome rates of all primary and secondary outcomes stayed relatively 
constant (see Fig. 2). We did not observe a significant underlying trend in primary or secondary outcomes over 
the study period in the regression models of our main analyses.
Results of main analysis. For the two primary and two out of three secondary outcomes, i.e. preterm 
birth, SGA, low birth weight and stillbirth, any effect on level changes or slope changes following implementa-
tion of the legislation in January 2008 was not statistically significant. We observed small effects with 95% con-
fidence intervals (CIs) that include a decrease as well as an increase of the outcome rates. Results are presented 
in Table 2 (rate ratios retrieved from exponential beta coefficients) and Fig. 2. These effect estimates can be 
interpreted as illustrated through the following example: For preterm births, we observed a rate ratio of 1.0163 
(95%CI 0.9762, 1.0580) for level change. This represents an immediate relative increase of 1.63% (95%CI − 2.38, 
5.80%) in the preterm birth rate (i.e. percentage of total births), which corresponds to a predicted increase in the 
preterm birth rate from 6.95 to 7.06% from December 2007 to January 2008. The calculated rate ratio of 0.9995 
(95%CI 0.9976, 1.0013) for the slope change represents a gradual decrease of 0.05% (95%CI − 0.24, 0.13%) in the 
preterm birth rate. This corresponds, for example, to a change in the predicted monthly preterm birth rate from 
7.031% in May 2008 to a rate of 7.025% in June 2008 and represents an average of two preterm births less every 
month after implementation of the intervention.
For the secondary outcome very preterm births we did observe a rate ratio of 0.8960 (95%CI 0.8413, 0.9542) 
for level change. This represents an immediate relative decrease of very preterm births by 10.40% (95%CI − 15.87, 
− 4.58%, p = 0.0006), corresponding to a level change from a very preterm birth rate of 0.98% in December 2007 
to 0.89% in January 2008. We also observed a rate ratio of 0.9954 (95% 0.9928, 0.9982) for a slope change in very 
preterm births. This represents a decrease of 0.46% (95%CI − 0.72, − 0.18%, p = 0.0010) in the very preterm birth 
rate, corresponding to an additional relative decrease from e.g. 0.983% in July 2009 to 0.979% in August 2009, 
representing four very preterm births less each month.
Subgroup and sensitivity analyses. Consistent with the main analysis, most of the subgroup and sensi-
tivity analyses showed small effects with confidence intervals suggesting that the effect could be in either direc-
tion (see Figs. 3 and 4 and Supplementary Fig. S2-7 online). The detailed results of the sensitivity and subgroup 
analyses are shown in Supplementary Table S1 online. Active smoking during pregnancy decreased throughout 
the study period (see Supplementary figure S8 online). For 284,421 deliveries (23%) smoking status information 
was missing and therefore not included in the subgroup analysis. The mean preterm birth rate was 2.48% (95%CI 
2.25–2.70%) and the mean SGA rate 10.52% (95%CI 10.18–10.86%) higher for smokers than for non-smokers 
(see Supplementary Fig. S9 and S10 online). We did not observe a statistically significant level or slope change 
in the number of smoking mothers following implementation of the intervention (level = − 1.53, 95%CI − 6.83, 
Figure 1.  Flow chart of study population and primary and secondary outcomes.
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4.06; slope = − 0.18, 95%CI − 0.45, 0.01). We further performed post-hoc sensitivity analyses for our secondary 
outcome very preterm birth where we could replicate our findings however without reaching statistical signifi-
cance (see Supplementary Table S2 online).
Discussion
This study is the first to assess the impact of smoke-free legislation on pregnancy outcomes conducted in Ger-
many. We did not observe clear immediate (level change) or gradual (slope change) effects of the smoke-free 
legislation on preterm birth, SGA, low birth weight and stillbirth; 95%-confidence intervals surrounding effect 
estimates suggest that the effect could be in either direction. Our findings were consistent across the majority of 
sensitivity and subgroup analyses.
We observed statistically significant immediate and gradual reductions for very preterm births. We could 
replicate these findings in the sensitivity and subgroup analyses especially for smokers; however, here the effects 
were not statistically significant, probably due to a lack of power considering the much smaller population. 
Although the preterm birth and SGA rates were higher for the most deprived quintile (BIMD 5) as compared 
to the least deprived (BIMD 1), consistent with the  literature4,11, we observed no clear differential effect of the 
legislation according to SES.
Table 1.  Maternal, newborn and subgroup characteristics by outcome; the numbers represent the number 
of newborns/mothers with the respective characteristic and the percentage of the births within the outcome 
group; SES = socio-economic status, BIMD = Bavarian Index of Multiple Deprivation, ranging from least 
deprived quintile (BIMD1) to most deprived quintile (BIMD5); SGA = small for gestational age, LBW = low 
birth weight; percent values are rounded to the second decimal place.
Maternal 
characteristics















 < 20 19,045 (1.54) 1,594 (1.90) 2,544 (2.27) 1,363 (2.24) 59 (1.90) 249 (2.26)
20–24 129,279 (10.45) 9,311 (11.13) 14,940 (13.32) 7,425 (12.22) 384 (12.35) 1,299 (11.80)
25–29 329,984 (26.67) 21,916 (26.19) 30,763 (27.43) 15,714 (25.86) 745 (23.96) 2,711 (24.64)
30–34 436,317 (35.27) 27,910 (33.35) 36,667 (32.70) 19,499 (32.09) 984 (31.65) 3,486 (31.69)
35–39 258,574 (20.90) 17,695 (21.14) 21,320 (19.01) 12,784 (21.04) 714 (22.97) 2,517 (22.88)
 ≥ 40 63,793 (5.16) 5,265 (6.29) 5,909 (5.27) 3,978 (6.55) 223 (7.17) 738 (6.71)
Missing 0 0 0 0 0 1 (0.01)
Parity
0 518,743 (41.94) 38,173 (45.61) 60,078 (53.57) 30,119 (45.57) 1,304 (41.94) 4,863 (44.21)
1 408,042 (32.99) 22,734 (27.16) 30,385 (27.09) 15,620 (25.71) 909 (29.24) 2,882 (26.20)
2 185,488 (15.00) 11,873 (14.19) 12,788 (11.40) 7,938 (13.06) 489 (15.73) 1,610 (14.64)
 ≤ 3 124,691 (10.10) 10,909 (13.03) 8,890 (7.93) 7,083 (11.66) 407 (13.09) 1,645 (14.95)
Missing 28 (0.00) 2 (0.00) 2 (0.00) 3 (0.00) 0 (0.00) 1 (0.01)
Smoking status
Smokers 69,156 (5.59) 6,240 (7.46) 12,974 (11.57) 6,846 (11.27) 248 (7.98) 901 (8.19)
Non-smokers 883,415 (71.42) 57,795 (69.10) 73,264 (65.53) 39,481 (64.98) 2,061 (66.29) 7311 (66.46)
missing 284,421 (22.99) 19,656 (23.49) 25,902 (23.10) 14,434 (18.82) 800 (25.73) 2,789 (25.35)
SES according to BIMD quintiles
BIMD 1 (least 
deprived) 163,522 (13.22) 10,677 (12.76) 13,569 (12.10) 7,402 (12.18) 404 (12.99) 1,263 (11.48)
BIMD2 147,174 (11.90) 9,823 (11.74) 12,876 (11.48) 6,921 (11.39) 338 (10.87) 1,185 (10.77)
BIMD3 168,880 (13.65) 11,366 (13.58) 15,095 (13.46) 8,222 (13.53) 399 (12.83) 1,413 (12.84)
BIMD4 362,012 (29.27) 23,660 (28.27) 32,558 (29.03) 17,333 (28.53) 895 (28.79) 3,145 (28.59)
BIMD5 (most 
deprived) 314,219 (25.40) 22,318 (26.67) 30,679 (27.36) 16,647 (27.40) 853 (27.44) 3,098 (28.16)
Missing 81,185 (6.56) 5,847 (6.97) 7,556 (6.74) 4,138 (6.81) 220 (7.08) 897 (8.15)
Nationality
German 999,383 (80.79) 67,699 (80.89) 90,647 (80.83) 49,011 (80.66) 2,367 (76.13) 8,403 (76.39)
Other nationality/
missing 237,609 (19.21) 15,992 (19.11) 21,496 (19.17) 11,752 (19.34) 742 (23.87) 2,598 (23.62)
Infant characteristics
Sex
Male 634,111 (51.26) 46,290 (55.31) 57,606 (51.37) 28,863 (47.50) 1,633 (52.52) 6,037 (54.88)
Female 602,881 (48.74) 37,401 (44.69) 54,537 (48.63) 31,900 (52.50) 1,476 (47.48) 4,963 (45.11)
Missing 0 0 0 0 0 1
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The literature shows mixed effects for the impact of smoke-free legislation on pregnancy outcomes, with a 
tendency towards a protective effect. Specifically, a recent systematic review and meta-analysis of mostly inter-
rupted time series (ITS) studies performed by Faber et al.4 observed an immediate drop (level change) in preterm 
birth, low birth weight, SGA and very preterm birth, but a gradual decline (slope change) only in SGA and very 
preterm birth. The effect estimates (risk differences) reported by the included studies were rather small for the 
outcomes preterm birth, SGA and low birth weight and greater for very preterm birth. In our study we observed, 
consistent with the meta-analysis in terms of relative effect size, unclear changes in all pregnancy outcomes fol-
lowing the smoke-free legislation except for very preterm birth.
In the absence of studies assessing pregnancy outcomes in Germany, up to now, only one published study 
employed a time series design to investigate the smoke-free legislation and found a short-term immediate 
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Figure 2.  Panel figure presenting time series of pregnancy outcomes in panels (a–e); dots represent the 
monthly percentages; white = pre-intervention period, grey = post-intervention period, red line = regression line; 
SGA = small for gestational age (R version 3.5.1, https ://www.r-proje ct.org/).
Table 2.  Estimates of level and slope changes in main analysis of primary and secondary outcomes; 
SGA = small for gestational age, LBW = low birth weight; All values are rounded to the fourth decimal place.
Outcome Rate ratio (95%CI)1 level change Rate ratio (95%CI) slope change Model type
Preterm birth 1.0163 (0.9762, 1.0580) 0.9995 (0.9976, 1.0013) Negative binomial model with autocorrela-tion terms
SGA 1.0063 (0.9839, 1.0292) 1.0005 (0.9995, 1.0014) Poisson model with seasonal dummies and autocorrelation terms
LBW 0.9861 (0.9484, 1.0254) 0.9983 (0.9966, 1.0000) Negative Binomial with seasonal dummies
Very preterm birth 0.8960 (0.8413, 0.9542), p = 0.0006 0.9954 (0.9928,0.9982), p = 0.0010 Negative binomial model with autocorrela-tion terms
Stillbirth 0.9583 (0.8165,1.1247) 1.0004 (0.9936, 1.0073) Poisson model
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effects of the legislation on smoking behaviour using German socio-economic panel (SOEP) data. It found no 
impact of the legislation in the general population but only for those frequenting bars and restaurants more 
 often12.
A previous study conducted in  Canada13 identified several factors, apart from methodological differences, 
that may explain the heterogeneous findings across studies assessing the effect of smoke-free legislation on 
pregnancy outcomes, namely: (i) different policy environments in terms of smoking prevalence and smoking 
norms, (ii) the presence of existing legislation prior to the smoke-free legislation under investigation, and (iii) 
differences in policy implementation and enforcement. These factors may contribute to understanding why we 
did not observe a clearer effect related to the Bavarian smoke-free legislation.
With regards to different policy environments, the smoking prevalence in other countries was similar to the 
prevalence in Germany, ranging from 18 to 27% among the female  population14–20. However, Germany, with a 
prevalence of 27% in 2008–2011 lies at the upper end of this  range21 and Germany’s efforts in tobacco control 
have been poor compared to other  countries22–24. According to the Tobacco Control Ranking Scale  201925, 
Germany occupies the last rank for successful implementation of tobacco control among 36 mostly European 
countries. For example, Germany currently is the only EU country, which still allows tobacco advertising on 
 billboards1. Tobacco smoking is a well-established risk factor for fetal growth restriction and preterm birth. 
Indeed, we found large differences between smoking and non-smoking mothers regarding rates of preterm 
birth and especially SGA. However, we did not observe any drop or gradual decrease of preterm birth or SGA 
rates in either subgroup following the implementation of the smoke-free legislation. Furthermore, we did not 
observe changes in smoking rates related to the implementation of the legislation as assumed in our logic model 
and shown in other  studies14,17,18. However, caution is merited, as a 5.9% smoking prevalence in our data is very 
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Figure 3.  Rate ratios with 95%CIs for level and slope changes of preterm birth, sensitivity (●) and subgroup 
(▲) analyses (R version 3.5.1, https ://www.r-proje ct.org/).
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more health-conscious behaviour among pregnant women, who, prior to implementation of the smoke-free 
legislation, already avoided exposure to second-hand smoke.
Considering pre-existing legislation, as laid out in our logic model, the smoke-free legislation is not the only 
factor influencing pregnancy outcomes, and we did identify co-interventions and existing legislation prior to 
implementation of the legislation under investigation that may have subdued a more prevalent effect.
Finally, regarding the role of policy implementation and enforcement, recent studies have shown that the 
health impact is larger when the smoke-free legislation is more  comprehensive4,26. While Bavaria has one of 
the strictest smoke-free legislations within Germany, the legislation lacked supporting interventions, such as 
an accompanying media campaign or tax increase. Studies in Spain, England and Scotland, where improve-
ments in pregnancy outcomes associated with legislation were observed, also found high compliance with the 
 legislation17,18,27. While we do not have data in Bavaria regarding actual enforcement or compliance, it is pos-
sible that the unclear effects could be explained by a lack of enforcement or compliance considering Germany’s 
lacking efforts in tobacco  control12,22,24.
The ITS study design is prone to certain methodological limitations. The lack of randomization and 
thus potential confounding make it difficult to definitely attribute causality to the intervention-outcome 
 relationship5,28. Beyond this design-inherent limitation, the use of rigorous a priori methods is important.
We used a high quality, large dataset and followed the steps outlined in the tutorial developed by Lopez Bernal 
et al.29 to account for common methodological and conceptual flaws in assessing population level interven-
tions with time series  designs30. In particular, we took a complex systems approach and used a logic model to 
conceptualize our study and identified co-interventions and other risk factors prior to conducting our  study31. 
We registered a detailed study protocol, in which we defined an impact model, the main statistical analysis, as 
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Figure 4.  Rate ratios with 95%CIs for level and slope changes of small for gestational age (SGA), sensitivity (●) 
and subgroup (▲) analyses (R version 3.5.1, https ://www.r-proje ct.org/).
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including the full range of data from 2000 to 2016, we would have come to different conclusions. However, in 
such a model the pre-intervention slope (and therefore level and slope change) was defined primarily by a major 
breakpoint in 2004 caused by several co-interventions in this year. This emphasizes the importance of choosing 
an appropriate impact model, as described by Lopez Bernal et al.32.
Our choice of the correct impact model, however, was also associated with several uncertainties. Many aspects 
of biological processes of pregnancy and especially the exact window of susceptibility of pregnancy to smoking 
are insufficiently  understood33,34. Also, the interrupted implementation of the legislation in Bavaria from 2008 
to 2010 makes it difficult to identify the exact time at which we can expect to see an effect. Some studies have 
investigated an immediate  onset18,19, or even an anticipatory intervention time  point17 whereas others have used 
an intervention time point nine months after the actual implementation of the  intervention13. A study which 
investigated the smoke-free legislation in the different cantons of Switzerland, found that the more time a mother 
spent under the smoke-free legislation the fewer were the risks for preterm birth and early-term  births20.
A further design-inherent weakness of the single-arm ITS study design is the lack of a concomitant, geo-
graphical control  group35. Indeed, a recent study has shown the limitations of single group ITS studies assessing 
the impact of smoke-free legislation on mortality in Spain where initial protective intervention effects from a 
single group ITS study were not confirmed after the addition of a comparable geographical control  site36. Despite 
careful preparation and consideration, we may have failed to identify important confounders or co-interventions, 
considering the complexity of the intervention as well as of the system in which it was implemented. Additionally, 
little concrete guidance on choice of statistical model exists, and determining the ‘best-fit’ model among a range 
of alternatives remains at least partially arbitrary. Gasparrini et al.37 already concluded that the model specifica-
tions, among other factors, have a strong impact on the effect estimate when assessing smoke-free legislation on 
acute myocardial infarction. We aimed, however, to define statistical parameters a priori, where possible, and to 
comprehensively report modelling choices by publishing our code alongside the manuscript.
Methods
We applied an ITS study design to assess the association between implementation of the smoke-free legislation 
and pregnancy outcomes using monthly data from all births in Bavaria between 2005 and 2016. The ITS study 
design is considered to be one of the best alternatives to assess intervention effectiveness of population-level 
interventions where randomization is considered  infeasible29,38. It is increasingly used in the field of healthcare 
and public  health39,40. This study design usually draws on routine data collected over time to identify any under-
lying time trends, and can thereby observe changes after the implementation of an intervention compared to 
a counterfactual scenario (i.e. a hypothetical scenario in which the intervention was not  implemented41). We 
pre-specified the study methods including the main impact model, main analysis, and subgroup and sensitivity 
analyses in a study protocol (available at www.drks.de, study ID: DRKS00014805).
Data source. We included aggregated data from a high-quality routine dataset of maternal and neonatal 
health indicators, collected and managed by the Bavarian Institute for Quality Assurance in hospital care (BAQ). 
This dataset contains all Bavarian in-hospital births, which constitute about 99% of all births in  Bavaria42. It 
provides extensive information retrieved from all hospitals in Bavaria regarding maternal and neonatal demo-
graphic and health-related characteristics, clinical management, and pregnancy complications. The data are sub-
jected to a series of formal and contextual plausibility  checks43.
Outcomes. Our primary outcomes included preterm birth (< 37 gestational weeks), and SGA (< the 10th 
percentile, adjusted for gestational age and sex based on Voigt et al.44), both measured as the percentage of these 
outcomes among all births that occurred during a given month. Secondary outcomes included monthly per-
centages of low birth weight (< 2500 g), very preterm birth (< 32 gestational weeks), and stillbirth (intrauterine 
death > 500 g).
Inclusion and exclusion criteria. We included all live and non-live singleton births from 24 until 42 com-
pleted weeks of gestation that occurred between January 2005 and December 2016. We excluded pregnancies 
with multiple births due to their increased risk of preterm birth, low birth weight and other pregnancy complica-
tions. We also excluded pregnancies with unknown gestational length and children with unknown birth weight.
Logic model. We developed a logic model that describes how the intervention and other factors influence 
pregnancy outcomes (see Fig.  5) to conceptualise the study and decide on the impact model and statistical 
analysis. The logic model, derived from literature searches, within-team discussions and expert consultations, 
provides a structure to help authors address complexity and thus better understand the interactions between the 
intervention, its implementation and multiple outcomes among a population and  context45,46.
We identified several co-interventions (i.e. other interventions, measures or policies that occur during the 
same time period) and other risk factors influencing pregnancy outcomes over the study period, which we 
describe in detail in our study protocol.
Impact model. The 16 German federal states are responsible for the implementation of the national law 
for the protection of non-smokers, and individual state legislation varies in strength (e.g. partial smoke-free 
laws), as well as in timing of implementation (ranging from August 2007 to July 2008). Bavaria implemented the 
smoke-free legislation on 1 January 2008. Thereafter, smoking was prohibited in all public buildings and institu-
tions, such as universities, hospitals, retirement and nursing homes, and restaurants and  bars47. Due to political 
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arguments, however, the Bavarian legislation was loosened on 1 August 2009, and smoking was permitted again 
in a subset of restaurants, e.g. in restaurants larger than 75  m2 mainly serving drinks. Following a referendum, 
which allowed Bavarian citizens to vote directly for or against more restrictive smoke-free legislation, the leg-
islation was tightened again on 1 August 2010. This iteration additionally banned smoking in beer and event 
 tents48,49, making the Bavarian smoke-free legislation one of the strictest in  Germany48. Violations of smoke-free 
legislation for smokers as well as event organisers include fines between 5 and 1,000 Euros, but information on 
enforcement and compliance is lacking.
We hypothesized that the effects of the smoke-free legislation may be detected as an immediate drop (level 
change) and gradual decline (slope change) in pregnancy outcomes at the first introduction of the smoke-free 
legislation on 1 January 2008. The changes could be the result of an immediate reduction in maternal exposure 
to SHS, and/or an immediate reduction in active maternal smoking (in public places and potentially elsewhere). 
They could also be impacted by longer-term influences on sociocultural norms, affecting smoking behaviours 
in different  settings50–52.
Originally, we planned to use data from 2000 to 2016 with equal time periods pre- and post-intervention. 
Upon visual inspection of the data we identified, however, a series of pronounced changes in outcome rates in the 
year 2004, during the pre-intervention period, that we were not able to sufficiently account for through adjust-
ments in the analysis. These changes were potentially triggered by the smoking ban at work in August  20047, a 
major cigarette price increase in September  200453, as well as a documentation change initiated in January 2004. 
Therefore, we shortened the pre-intervention time period, using data from 2005 to 2016. The main impact model 
is therefore based on a pre-intervention period from January 2005 to 31 December 2007 and a post-intervention 
period from 1 January 2008 until 31 December 2016. We report, however, additional sensitivity analyses using 
data from 2000 to 2016.
Statistical analyses. We performed a segmented regression analysis using a generalized linear model with 
log-link for all  analyses29,36. As the analysed monthly data were not independent from one another, we adjusted 
for seasonality through the inclusion of monthly dummy variables and/or for autocorrelation through the inclu-
sion of auto-regressive structures in the model. We performed goodness-of-fit tests to decide whether to use 
a Poisson or a more flexible Negative Binomial model. We scrutinized auto-correlation function (ACF) and 
partial auto-correlation function (PACF) plots visually and compared Akaike’s information criteria (AIC) to see 
whether the model performed better after adjustment for seasonality and/or remaining autocorrelation.
Figure 5.  Logic model of the Bavarian smoke-free legislation.
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The final models were generalized linear models (Poisson or Negative Binomial depending on the outcome) 
including seasonal dummy variables and/or a random effect term comprising the appropriate autoregressive 
terms. As we were dealing with count data, we were using the population as an offset variable in order to trans-
form back to rates. The main statistical formula is depicted below:
where t is the log of monthly outcome rates measured at each month of observation t, and timet is a continuous 
variable modelling each month since January 2005 (1,2,3…–145), levelj a binary predictor for the legislation, 
which is modelled as 0 in the pre-legislation time period (January 2005–December 2007) and 1 in the post-
legislation period (January 2008–December 2016). slopejt is an interaction term of the legislation with time. In 
this model β0 represents the baseline outcome rate, β1 the change in outcome rate per one unit increase in time 
(month) (i.e. the underlying pre-legislation trend), β2 the level change in outcome following the legislation and 
β3 the slope change in outcome following the legislation.
We performed data management with SAS software version 9.454, and the analyses using  R55. The complete 
R code for the main statistical analysis is available in the Supplementary Information online.
Subgroup and sensitivity analyses. We specified a series of sensitivity and subgroup analyses a priori 
for the primary outcomes preterm birth and SGA (see Table 3). We further performed post-hoc sensitivity analy-
ses for the secondary outcome very preterm birth to verify the findings in the main analysis.
Ethics statement. As we use anonymous, routinely collected data, separate ethics approval was not required 
for this study, as confirmed by a waiver obtained from the ethics commission of the LMU Munich. The Bavarian 
Institute for Quality Assurance in hospital care (BAQ) approved the use of the data.
Data availability
The data that support the findings of this study are available from the Bavarian Institute for Quality Assurance 
in hospital care (BAQ) but restrictions apply to the availability of these data, which were used under license for 
the current study, and so are not publicly available. Data are however available from the authors upon reasonable 
request and with permission of BAQ.
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Table 3.  Sensitivity and subgroup analysis descriptions.
Sensitivity analyses
Varying time lags
We tested different intervention time points with three and six month time lags to assess if our assumption that smoking can affect pregnancy 
outcomes at any stage during pregnancy was correct
Excluding transition period
We excluded the data from 1 January 2008 (when the first smoking ban was implemented) until 1 August 2010 (when the smoking ban was 
reinstated) to compare the time period prior to the first ban to the period after implementation of the tightened ban
Including a longer pre-intervention period (2000–2016) (post-hoc)
We analysed the originally planned impact model with a study period from 2000 to 2016
Excluding induced births
We analysed spontaneous preterm births only, as smoking is associated with the spontaneous preterm onset of labour due to the inflamma-
tory responses it triggers and higher risk of intrauterine uterine infections (Goldenberg, Culhane, Iams, & Romero, 2008). We could thereby 
also account for the potential effects of the introduction of gestational diabetes screening in  201156, which is associated with induced preterm 
births
Excluding preterm infants at the border of viability
We excluded infants born between 24 and 27 completed gestational weeks and only assessed infants born between 28 and 36 gestational 
weeks to rule out any effect of changes in data documentation practices after implementation of the guidelines on premature infants on the 
border of  viability57
Including only mothers of German nationality
We excluded all mothers born outside of Germany to rule out any effect of the recent increase in refugees starting in 2014 in Germany
Subgroup analyses
Smoking status
We tested if outcomes rates differed between actively smoking and non-smoking mothers (see Mackay et al.17). Smoking, as reported by the 
mother, is recorded when registering in hospital. We further assessed post-hoc whether the smoking rates differed after implementation of 
the smoke-free legislation
Socio-economic status (SES)
We wanted to assess the impact of tobacco control policies on marginalised populations and assessed whether the legislation had a different 
effect on different socio-economic groups. Individual-level SES data were not available, and we thus used the area-level Bavarian Index of 
Multiple Deprivation (BIMD) as a proxy for individual  SES58,59. We therefore assigned each mother a BIMD quintile based on the postal code 
of her residential address. We then performed subgroup analyses according to each BIMD quintile
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